All Stories

  1. Prevalence of chronic cough, its risk factors and population attributable risk in the Burden of Obstructive Lung Disease (BOLD) study: a multinational cross-sectional study
  2. Assessing the Feasibility of a Multifaceted Intervention Package for Improving Respiratory Health of Textile Workers: Findings From the MultiTex Pilot Study in Karachi, Pakistan
  3. Fungal empyema thoracis, a rare but an emerging entity: a retrospective case series from Pakistan
  4. Allergic bronchopulmonary aspergillosis: radiological and microbiological profile of patients presented in an outpatient pulmonary clinic in a developing country
  5. Aspergillus-specific IgG antibodies for diagnosing chronic pulmonary aspergillosis compared to the reference standard
  6. Cohort Profile: Burden of Obstructive Lung Disease (BOLD) study
  7. Prevalence and factors associated with respiratory symptoms in an urban population: findings from BOLD study in Karachi, Pakistan
  8. Non-cystic fibrosis bronchiectasis: a retrospective review of clinical, radiological, microbiological and lung function profile at a tertiary care center of low-middle income country
  9. Four-Month High-Dose Rifampicin Regimens for Pulmonary Tuberculosis
  10. Chronic airflow obstruction attributable to poverty in the multinational Burden of Obstructive Lung Disease (BOLD) study
  11. Impact of immune status on the clinical characteristics, treatment outcomes and mortality of pulmonary nocardiosis: a retrospective analysis in a tertiary care hospital from a low to middle-income country
  12. Bilateral pneumothorax in a patient with angiosarcoma of the scalp: a case report
  13. GRADE-ADOLOPMENT of clinical practice guidelines and creation of clinical pathways for the primary care management of chronic respiratory conditions in Pakistan
  14. Clinical characteristics, outcomes, and factors associated with mortality in Nocardia pneumonia: 18 years' real-world data from a tertiary care hospital in Karachi, Pakistan
  15. Byssinosis and lung health among cotton textile workers: baseline findings of the MultiTex trial in Karachi, Pakistan
  16. Post-COVID-19 Pneumocystis pneumonia cases from Pakistan: an observational study
  17. Diagnostic accuracy of different cut-off values of adenosine deaminase levels in tuberculous pleural effusion
  18. Factors predicting mortality among patients with COVID-19 associated hospital acquired pneumonia: Insights from a tertiary care center
  19. <xhtml:span xmlns:xhtml="http://www.w3.org/1999/xhtml" xml:lang="en">Comparison of diagnostic accuracy of Xpert MTB/RIF and Geno type MTBDRplus line probe assay for diagnosis of tuberculous pleural effusion </xhtml:span>
  20. Tuberculosis and diabetes mellitus: Relating immune impact of co-morbidity with challenges in disease management in high burden countries
  21. Post COVID-19 sequelae of the respiratory system. A single center experience reporting the compromise of the airway, alveolar and vascular components
  22. Clinical features, microbiology and lung function in post-TB bronchiectasis compared to other aetiologies
  23. Differences in gender perception of smokeless tobacco
  24. Indoor Air Pollution and Respiratory Health in a Metropolitan City of Pakistan
  25. Treatment outcome definitions for chronic pulmonary aspergillosis
  26. The effect of ivermectin on non-severe and severe COVID-19 disease and gender-based difference of its effectiveness
  27. Latent M. tuberculosis infection is associated with increased inflammatory cytokine and decreased suppressor of cytokine signalling (SOCS)‐3 in the diabetic host
  28. Pesticides Use and Impaired Lung Function Among Male Agricultural Farmers in Rural Sindh, Pakistan
  29. Allergic bronchopulmonary aspergillosis misdiagnosed as smear negative pulmonary tuberculosis; a retrospective study from Pakistan
  30. Post tuberculosis radiological sequelae in patients treated for pulmonary and pleural tuberculosis at a tertiary center in Pakistan
  31. Diagnostic dilemma in COVID-19-associated pulmonary aspergillosis
  32. Chronic airflow obstruction and ambient particulate air pollution
  33. Respiratory pathogens in patients with acute exacerbation of non-cystic fibrosis bronchiectasis from a developing country
  34. Post COVID-19 tuberculosis: An emerging threat of pandemic
  35. Prevalence of and risk factors for respiratory symptoms in an adult urban population
  36. COVID-19 Associated Interstitial Lung Disease - An Emerging Entity
  37. “Allergic Bronchopulmonary Aspergillosis: Radiological and Microbiological Profile of Patients Presented in an Outpatient Pulmonary Clinic of a Developing Country”.
  38. Invasive pulmonary aspergillosis in patients with severe influenza
  39. Aspergillus fumigatus and Aspergillus flavus-Specific IgG Cut-Offs for the Diagnosis of Chronic Pulmonary Aspergillosis in Pakistan
  40. Alternate diagnosis in clinically diagnosed pulmonary tuberculosis patients treated at tertiary care hospital in a high TB burden country
  41. Clinical characteristics and outcomes of patients with H1N1 influenza pneumonia admitted at a tertiary care hospital in Karachi, Pakistan
  42. Factors predicting in‐hospital mortality among patients admitted with community acquired pneumonia at a tertiary care hospital Karachi, Pakistan
  43. Underlying Conditions and Clinical Spectrum of Chronic Pulmonary Aspergillosis (CPA): An Experience from a Tertiary Care Hospital in Karachi, Pakistan
  44. Etiology, Clinical, Radiological, and Microbiological Profile of Patients with Non-cystic Fibrosis Bronchiectasis at a Tertiary Care Hospital of Pakistan
  45. Commemorating World TB Day 2020: “IT’S TIME” — It’s time to End the Global TB Epidemic
  46. Post tuberculosis treatment infectious complications
  47. Accuracy of genotype MTBDRplus line probe assay in patients with tuberculous pleural effusion: comparison with clinical and culture based diagnosis
  48. International prevalence and risk factors evaluation for drug-resistant Streptococcus pneumoniae pneumonia
  49. Prevalence and risk factors for Enterobacteriaceae in patients hospitalized with community‐acquired pneumonia
  50. Visual and treatment outcomes of tubercular uveitis: a prospective case series from a referral hospital in Pakistan
  51. Utility of the microcolony method for evaluation of multidrug-resistant tuberculosis patients in Karachi, Pakistan
  52. An international perspective on hospitalized patients with viral community-acquired pneumonia
  53. Epidemiology of asthma and associated factors in an urban Pakistani population: adult asthma study-Karachi
  54. Microbiological testing of adults hospitalised with community-acquired pneumonia: an international study
  55. Post tuberculosis sequelae in patients treated for tuberculosis: An observational study at a tertiary care center of a high TB burden country
  56. Prevalence and Etiology of Community-acquired Pneumonia in Immunocompromised Patients
  57. Case Definition of Chronic Pulmonary Aspergillosis in Resource-Constrained Settings
  58. Burden and risk factors forPseudomonas aeruginosacommunity-acquired pneumonia: a multinational point prevalence study of hospitalised patients
  59. Disseminated hydatid cyst of liver and lung
  60. Case of undiagnosed pneumocystis pneumonia (PCP)
  61. Association of hypercapnia on admission with increased length of hospital stay and severity in patients admitted with community-acquired pneumonia: a prospective observational study from Pakistan
  62. Clinical characteristics and factors associated with mortality in idiopathic pulmonary fibrosis: An experience from a tertiary care center in Pakistan
  63. Chronic pulmonary mucormycosis: an emerging fungal infection in diabetes mellitus
  64. Diagnostic performance of genoType® MTBDRplus line probe assay in bronchoalveolar lavage for pulmonary tuberculosis diagnosis in sputum scarce and smear-negative patients
  65. Global initiative for meticillin-resistant Staphylococcus aureus pneumonia (GLIMP): an international, observational cohort study
  66. Clinical manifestations and outcomes of pulmonary aspergillosis: experience from Pakistan
  67. Endobronchial tuberculosis—a review
  68. Assessment of diabetes among tuberculosis patients presenting at a tertiary care facility in Pakistan
  69. Increased Mycobacterium tuberculosis antigen-induced gene expression of interferon-gamma, tumor necrosis factor alpha and interleukin-6 in patients with diabetes
  70. Post-tuberculosis pulmonary function and noninfectious pulmonary disorders
  71. Behaviour change intervention for smokeless tobacco cessation: its development, feasibility and fidelity testing in Pakistan and in the UK
  72. Reasons for failure to quit: a cross-sectional survey of tobacco use in major cities in Pakistan
  73. Prevalence of tobacco use among women: a cross sectional survey from a squatter settlement of Karachi, Pakistan
  74. Pulmonary scedosporiosis mimicking aspergilloma in an immunocompetent host: a case report and review of the literature
  75. Endobronchial tuberculosis presented as multiple endobronchial vesicular lesions
  76. Sarcoidosis presented as retroperitoneal and lung mass
  77. Compliance with continuous positive airway pressure (CPAP) therapy for obstructive sleep apnea among privately paying patients- a cross sectional study
  78. Differential Early Secreted Antigen Target (ESAT) 6 kDa–induced IFN-γ and SOCS1 expression distinguishes latent and active tuberculosis
  79. Death certificate completion skills of hospital physicians in a developing country
  80. Community-acquired pneumonia
  81. Expression of M. tuberculosis-induced suppressor of cytokine signaling (SOCS) 1, SOCS3, FoxP3 and secretion of IL-6 associates with differing clinical severity of tuberculosis
  82. Factors Associated within 28 Days In-Hospital Mortality of Patients with Acute Respiratory Distress Syndrome
  83. BCG vaccination is associated with decreased severity of tuberculosis in Pakistan
  84. Pulmonary functions in patients with diabetes mellitus
  85. Lung function decrement with arsenic exposure to drinking groundwater along River Indus: a comparative cross-sectional study
  86. The Efficacy of Spirometry as a Screening Tool in Detection of Air Flow Obstruction
  87. CCL2 Responses to Mycobacterium tuberculosis Are Associated with Disease Severity in Tuberculosis
  88. Differential Live Mycobacterium tuberculosis-, M. bovis BCG-, Recombinant ESAT6-, and Culture Filtrate Protein 10-Induced Immunity in Tuberculosis
  89. Rapidly progressive cryptogenic organising pneumonia presenting as a lung mass
  90. Relationship between Circulating Levels of IFN-γ, IL-10, CXCL9 and CCL2 in Pulmonary and Extrapulmonary Tuberculosis is Dependent on Disease Severity
  91. Drug susceptibility pattern of Mycobacterium tuberculosis in adult patients with miliary tuberculosis